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production of growth factors
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Medical Research Council, Clinical and Population Cytogenetics Unit, Western General Hospital, Crewe Road,
Edinburgh EH4 2XU, UK.
Summary Three factors may be responsible for the sharp difference in tumourigenicity between cloned
murine fibrosarcoma lines maintained in vitro, and cells of the same lines after in vivo passage, initially in a T
cell deficient mouse and subsequently in normal mice: (1) acquisition during passage of resistance to NC cells;
(2) acquisition during passage of a surface molecule, probably a sialic acid, which protects the cell against T
cell-mediated lysis; and (3) ability of the passaged cells, but not the non-passaged cells, to produce sufficient
amounts of autocrine growth factors necessary for growth in vivo. The tumourigenicity of the passaged cells
cannot be attributed to failure to express TATA or MHC class I molecules.
As reported previously (Woodruff & Hodson,
1985a,b), cloned lines of strongly immunogenic
chemically-induced murine fibrosarcomas maintained
in vitro usually fail to grow when transplanted to
normal mice, whereas they grow readily in T cell
deficient mice, and after passage in such mice grow
readily in normal mice.
The non-transplantability of the cultured lines is
not associated with increased immunogenicity; nor
can the effect of passage be attributed, as a general
rule, to the emergence of NK/NC cell* resistant
cells, though this may be a factor with some clones.
We have already suggested two other possible
explanations and now add a third:
1. After passage in T cell deficient hosts the
tumour cells fail to express a class I MHC
molecule required for dual recognition. Such
cells would not be susceptible to T cell mediated
lysis, though for reasons discussed previously
(Woodruff & Hodson, 1985b) they might still be
immunogenic.
2. During passage in T cell deficient hosts the
tumour cells acquire a protective surface
molecule, or the capacity to make such a
molecule, which enables them to survive when
subsequently transplanted to normal hosts.
3. Cloning selects cells capable of growing in vitro
in the absense of growth factors produced by
other tumour cells of the same kind. Cells
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*The nomenclature for NK and NC cells is confused.
Our use of these designations is as explained in the first
paper in this series (Woodruff & Hodson, 1985a). A fuller
discussion will be found in a recent review (Woodruff,
1986).
selected in this way may, in consequence, lack
the capacity to synthesise autocrine growth
factors needed for growth in vivo and/or
receptors for such factors, but grow in vitro
because they can utilize instead growth factors
present in FCS.
We report experiments designed to discriminate
between these possibilities.
Materials and methods
Tumours
The origin of, and methods of propagating, the
fibrosarcoma lines have been described previously
(Woodruff & Hodson, 1985a). We have used mainly
4 different clones (W319, C6 and C12; W324, C17
and C57), distinguished by their origin from a
different tumour or by a difference in PGK-1
alloenzyme phenotype. In one set of experiments we
have also used clones 5, 8 and 9 of tumour W319,
but these, like W319 C12, all express PGK-1 B
and there is evidence (Woodruff et al., 1986) which
suggests that these are all derived from the same
clone of transformed cells. As before, the suffixes C
and M indicate lines maintained in tissue culture
and by serial transplantation respectively; the suffix
MC indicates an M line which was cultured in vitro
for 24 or 48h.
The CBA/Ca mice in which the M lines were
maintained, and the CBA backcross mice in which
the tumours were induced, are H2k. A fibrosarcoma
(WI45) induced with methylcholanthrene in a
BALB/c mouse (H2d) was used as a negative
control in testinj tumour clones for expression of
H2Dk and H2K . As a positive control we have
used an AKR leukaemia (F369) which expresses
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H2Kk; this was kindly made available by Professor
H. Festenstein.
Testsfor expression ofH2Dk and H2Kk by tumour
clones
The cells were incubated for 60 minutes on ice with
monoclonal antibody (MAb) anti-H2Dk (Hybridoma
ATCC No. HB24; source references, Ozato et al.,
1980) or anti-H2Kk (Hybridoma ATCC No. TIB95;
source reference Oi et al., 1978), washed, and
reincubated (45min on ice) with an optimal dilution
(1/30-1/50) of either F(ab')2 rabbit-anti-mouse Ig
conjugated with FITC (Miles-Yeda Ltd, Rehovot,
Israel; code 65-171) or F(ab')2 sheep-anti-mouse
Ig labelled with 1251 (Amersham International,
Amersham, UK; IM 1210). The FITC labelled cells
were analysed by fluorescence activated cell sorting
on a Becton Dickinson FACS IV; the radioactively
labelled cells were counted for 1251 in triplicates on
a scintillation spectrometer (LKB Willac 80000).
Lectin binding
Frozen cell pellets from C, M and MC cells were
lysed in 1% NP40 buffer (5 x 107cellsml-1 tris-
NaCl buffer) and separated on 8-15% SDS-PAGE
gradient gels (Laemmli, 1970). Separated material
was then transferred electrophoretically to cellulose
nitrate (Western blotting) (Towbin et al., 1979).
Lectin binding was visualised by autoradiography
using 125I-labelled wheatgerm (WGA), gorse, Helix
pomatia, lentil and peanut lectins. Some lysates
which had been treated with neuraminidase to
remove exposed sialic acid residues were similarly
analysed.
Assaysfor growthfactors in vitro
Supernatants from culture flasks seeded 24-48 h
previously with M or C cells in MOPS-buffered
Ham's FIO medium with 10% FCS (referred to
hereafter as Med), and which had become -80%
confluent, were harvested and stored (up to 1 week)
at -40°C. Assays were performed using microtest
plates (Falcon II) seeded with 104 M or MC cells in
0.2ml Med. After incubation for 24h at 370C,
0.05pCi 1251UDR (Amersham International,
Amersham, UK) in 20yl Med was added to each
well, followed immediately by 50,ul of culture
supernatant or Med. After a further 24h incubation
the plates were shaken, washed, dried and sprayed
with Nobecutane as described previously (Woodruff
& Hodson, 1985b). The floor of each well was then
punched out and counted for 1251. There were 3
replicates for each combination of cells and culture
supernatant.
Growth oftumours in vivo after injection ofmixed
cellpopulations
Mixtures consisting of a C line and an M line
from the same or different clones were injected
subcutaneously to CBA/Ca mice (R or L hind
limb). In some cases the mice were immunized
against one of the clones by injection of 106
irradiated (220 Gy) cells 14 days previously.
Tumours which grew were tested as previously
described for expression of PGK-1 A and PGK-1 B
alloenzymes in cases in which both PGK-1
phenotypes were represented in the original
mixture.
Details of the various mixtures are shown with
the results in Table III.
Results
Expression ofH2Dk and K* by tumour clones
A typical FACS plot is shown in Figure 1, and a
summary of the results in Table I, which shows
that the passaged cells consistently expressed not
less but as much or more of both the D and K
molecules as the non-passaged cells. The first
hypothesis under consideration can therefore be
ruled out.
Lectin binding
Binding studies with wheat germ lectin, but not
with any of the other lectins tested, revealed extra
glycoprotein components in the molecular weight
range 150-180Kd in lysates of mouse passaged
lines of all except one of the clones tested (i.e. in
W319 C5, 8, 9, 12 and W324 C17, but not in W319
C6) which were not present in lysates of cells of the
corresponding cultured lines. With some, though
not all, clones (Figure 2) the extra band(s)
suggested a frame shift upwards of components
expressed by the cultured lines. Cells taken from
the initial passage in the immunosuppressed host
showed the same alteration in pattern as cells from
the corresponding established passaged line. For
each tumour tested it made no difference whether
the cell lysates were prepared from M cells or MC
cells (Figure 3A, B, C) or even from cells
maintained in culture for up to 14 days.
Pretreatment of cell lysates with neuraminidase
reduced these differences and, in particular,
removed the extra band of approximately 180Kd
expressed by passaged cells (Figure 3D, E). It
would seem therefore that with these clones in vivo
passage resulted in increased sialylation of certain
high molecular weight glycoproteins exposed on the
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Figure 1 Typical FACS plot showing the results of analysis of (a) non-passaged and (b) mouse passaged
cells of tumour W312 Clone 12 for H2Kd. In both (a) and (b) the left hand peak is the negative control
(Balb/c tumour W145 treated with the same MAb). Relative cell numbers are plotted vertically (linear scale);
log fluorescence intensity is plotted horizontally.
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Table I Expression of H2Dk and H2Kk molecules by passaged and non-passaged tumour clones.
Mean cpm less backgroundb
per 105 cells. First antibody
% Positive cells in FACSa shown at head ofcolumn
Tumour and Passaged
clone in mouse H2Dk H2Kk Anti-H2Dk Anti-H2Kk
319 C6 NO 26.9 12.7 466 540
YES 90.2 20.3 624 1541
319 C12 NO 56.0 63.5 685 2024
YES 94.3 79.5 1419 3911
324 C17 NO 92.7 49.9 1710 3929
YES 98.8 98.9 1468 5038
324 C57 NO 38.9 23.1 959 2851
YES 89.5 43.7 1104 3285
+control AKR
tumour F369 YES 1188 3273
-control Balb/c
tumour W145 YES 3.3 8.4 114 0
aDetermined by gating on the negative control. bSecond
details of first and second antibodies.
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Figure 2 1251 WGA binding to NP40 cell lysates after SDS-PAGE and Western blotting.
(A) Non-passaged (C) and (B) passaged (MC) cells from W319 C5.
(C) Non-passaged (C) and (D) passaged (MC) cells from W319 C12.
(E) Non-passaged (C) and (F) passaged (MC) cells from W324 C17.
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Figure 3 125 WGA binding to NP40 cell lysates after SDS-PAGE and Western blotting. Cells of W324 C17.
(A) Non-passaged (C) cells.
(B) Cells from tumours passaged once in T cell deficient mouse (M cells).
(C) Passaged cells cultured for 48 h (MC cells).
(D) Cells as (A). Lysate treated with neuraminidase.
(E) Cells as (C). Lysate treated with neuraminidase.
Assay ofculture supernatantsfor growthfaictors
The results are summarised in Table II. As will be
seen, supernatants from cultures set up with MC
cells usually, though not always, stimulated uptake
of 125IUDR by both C cells and MC cells from the
same clone, or from different clones derived from
the same tumour, though some supernatants were
more stimulating than others. Supernatants from
cultures set up with C cells had little or no
stimulating effect, or a weaker effect than the
corresponding MC supernatants. This is consistent
with the hypothesis that the C cells are non-
tumourigenic because they lack the capacity to
synthesise adequate amounts of growth factor
needed for them to grow in vivo, though they do
possess appropriate growth factor receptors.
Growth oftumours in vivofrom mixed MC and C
cells
Details of the mixtures used and the results are
shown in Table III.
These experiments were set up to test further the
hypothesis based on the results of assays of culture
supernatants discussed in the preceding section. The
results, however, neither confirm nor refute the
hypothesis because the observed failure of MC cells
to promote the survival of C cells in vivo may mean
only that when conditions are such that the MC
cells grow readily they simply outgrow the C cells,
whereas when the MC cells fail to become
established, because they are too few in number, or
because the host has been immunized against them,
they do not provide growth factor(s) in sufficient
quantity or for a sufficiently long time, to enable
the C cells to become established.
Discussion
The evidence presented in this and the preceding
two papers points to the conclusion that at least
three factors, alone or in combination, may be
responsible for the marked difference in tumouri-628 M.F.A. WOODRUFF et al.
Table II Assay of supernatants of cultured tumour clones for growth stimulating activity by '25IUDR uptake.
Clones used in the assay
Counts ofresidual adherent cells in microwells (mean cpm+s.e.)a
Cells in culture
providing the 319C6 319C6 319C12 319C12 324C12 324C17 324C57 C324C7
supernatant C M C M C M C M
319C6C 106+5 1181+186 1338+106 28+ 10
319C6M 928+77 2976+311 2273+106 336+48
319C12C 213+15 248+20 480+5 38+8
319C12M 420+34 3222+212 2347+252 146+33
324C17C 355+5 388+14 336+36 38+2
324C17M 1750+37 2924+170 2823+165 44+11
325C57C 170+11 385+55 335+36 28+3
325C57M 717+31 1045+130 889+42 30+5
No cellsb 605+12 515+67 846+116 33+5 528+77 264+41 867+170 28+7
aValues which differ from the control value by more than 3 times their s.e. are in italic. "The figures in this row
relate to control wells in which medium +FCS was used instead ofculture supernatant.
Table III Growth of tumours in CBA mice after injection of mixtures of mouse passaged (MC) and non-passaged (C)
cells.
No. of No. ofmice Clonal
Treatment Cells injected (W319 clones) mice which developed composition
ofhost MC cells + C cells injected tumours oftumours Comments
105C6MC nil (controls) 3 3
104C6MC nil (controls) 8 8
Nil 103C6MC nil (controls) 8 6
3 x 1O2C6MC nil (controls) 5 1
102C6MC nil (controls) 3 1
105C6MC 106C6C 3 3 The origin ofthe tumour
104C6MC 106C6C 8 5 cannot be established with
103C6MC 106C6C 8 3 certainty but comparison
Nil 3 x 102C6MC 106C6C 5 0 ofthe incidence of
102C6MC 106C6C 5 0 tumours in these mice and
10 C6MC 106C6C 5 0 mice which received MC cells
102C6MC 105C6C 5 0 only in the same dosage
10 C6MC 105C6C 5 1 strongly suggests that
they all originated from
MC cells
106C12MC 106C6C 5 5 C12 only Clearly only the MC cells
3 x 1O5C12MC 106C6C 5 5 C12 only were tumourigenic Nil 105C12MC 106C6C 5 5 C12 only
nil (controls) 106C6C 5 0
Preimmunized 106C12MC 106C6C 3 0
by injection
106 irrad. 3x15C12MC 106C6C 3 0
C12 M cells
Day- 14 105C12MC 106C6C 3 0
genicity between cloned murine fibrosarcoma lines
maintained in vitro and cells of the same lines after
passage in vivo, initially in a T cell-deficient mouse
and subsequently in normal mice.
With one clone (W319 C6) resistance to NC cells
increased during the initial passage and this
increase was maintained during subsequent
passages. Other clones from this tumour (W319 C5,
C8, C9, C12), and a clone from another tumour
(324 C17) did not show a change in NC sensitivity
on passage, but lectin binding studies revealed
increased sialylation of high molecular weight cellEFFECT OF PASSAGE ON MURINE FIBROSARCOMAS 629
surface glycoprotein on passage which, we
postulate, protects the cell against T cell-mediated
lysis. This hypothesis is rendered plausible by the
fact that malignant transformation is often
associated with changes in the carbohydrate
composition of many cell surface components
(Yogeeswaran, 1983). Moreover, changes of the
kind we have observed can mask a variety of cell
surface target molecules because increased
sialylation imparts a net negative change to the
molecule, and possibly to the cell surface as a
whole (Schauer, 1985). The abnormal lectin binding
cannot be attributed to contaminating non-
transformed cells in the mouse-passaged line
because most of these cells are removed by the
culture procedure (Woodruff et al., 1982); abnormal
surface glycoprotein produced by such cells would
therefore be much less abundant in MC cells than
in the corresponding M cells, but both gave the
same banding pattern.
At first sight the observation of a particular
surface change on passage in 5 out of 6 clones
tested suggests that this phenomenon is of frequent
occurrence. More experiments with clones from
many different tumours would be required to
establish this, however, because many of our
tumours appear to be biclonal (Woodruff et al.,
1986), and the four W319 clones with the property
in question, which all expressed PGK-1 B, may
have been derived from the same original clone of
transformed cells. If this is the case, the capacity to
change in the way described on passage is clearly a
stable property of the clone in question.
The third factor, which does not apply to clone
W319C6 but applies to the other clones tested, is
the inability of non-passaged lines to produce
sufficient amounts of growth factors needed for
growth in vivo, though they do not lack receptors
for such factors. This inability is not surprising
because in the process of cloning in vitro the
selective advantage lies with single cells that can
take advantage of growth factors in FCS or which
are provided by a feeder layer of non-transformed
cells in the absence of other transformed cells of
their own kind.
Whatever the explanation, the phenomenon we
have described highlights the need for caution in
interpreting observations made with established cell
lines, especially cloned lines, that have not been
recently passaged. With animal tumours it should
be possible to passage the cells in an isogenic host
(if necessary T cell deficient), and compare their
behaviour, as we have done, with that of
unpassaged cells of the same line. This option is not
available with human tumours, but it might be
rewarding to study the effects of passage in an
appropriate xenogeneic host such as the nude
mouse.
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